# Cyprotex PLC — Form D

Cyprotex PLC of MANCHESTER, X0, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-17. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-08-17
- Form: D
- Accession: 0001499299-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.7M
- Amount sold: $2.7M
- Investors: 2
- Date of first sale: 2010-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146539

## Issuer

- Name: Cyprotex PLC
- CIK: 0001499299
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Address: 100 BARBIROLLI SQUARE, MANCHESTER, X0, M2 3AB
- Phone: 44 (0) 1625 505100

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Anthony David Baxter | Director | Manchester, X0 |
| John Kevin Dootson | Director | Manchester, X0 |
| Ralph Stephen Harris | Director | Manchester, X0 |
| Anthony David Baxter | Executive Officer | Manchester, X0 |
| John Kevin Dootson | Executive Officer | Manchester, X0 |

## More

- [CIK 1499299 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1499299&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001499299-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.